Wymzya Fe(Noreth-Ethinyl Estradiol/Iron)
LUPIN.NS
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Lupin Limited
$5,226
Medicare cost, 2024
$5,226
Medicare cost, 2024
Medicare drug plans spent $5,226 on Wymzya Fe (noreth-ethinyl estradiol/iron) in 2024, for 48 prescriptions and refills filled by 12 patients. It is made by Lupin Limited (LUPIN.NS).
Medicare cost, 2024
$5,226
-12.2% from 2023
Prescriptions
48
$108.88 per claim
Patients
12
15 prescribers
Total spending, 2024
$5,226
$435.51 per patient
Questions and answers
How much does Medicare spend on Wymzya Fe?
Medicare prescription drug plans paid $5,226 for Wymzya Fe in 2024, for 48 prescriptions and refills to 12 patients (down 12.2% from 2023). The average cost per claim was $108.88.
Who makes Wymzya Fe?
Wymzya Fe is made by Lupin Limited (LUPIN.NS), listed in the Medicare spending data as Lupin Pharmaceu.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Wymzya Fe was $5,226 in 2024, after a high of $40K in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 55 | 166 | 49 | $15K |
| 2023 | 19 | 63 | 17 | $5,953 |
| 2024 | 15 | 48 | 12 | $5,226 |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Lupin Pharmaceu | 48 | $5,226 |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.